Sat.Sep 14, 2024 - Fri.Sep 20, 2024

article thumbnail

Episode 354: Antiracism in Medicine – Episode 25 – Live from SGIM 2024: Best of Antiracism Research at the Society of General Internal Medicine’s 2024 Annual Meeting

The Clinical Problem Solvers

[link] CPSolvers: Anti-Racism in Medicine Series Episode 25 – Live from SGIM 2024: Best of Antiracism Research at the Society of General Internal Medicine’s 2024 Annual Meeting Show Notes by Ashley M. Cooper September 19, 2024 Summary : This episode highlights a selection of antiracism research presentations at a live recording of the podcast at the 2024 SGIM Annual Meeting.

article thumbnail

Need to See a Doctor Fast? Here’s How Urgent Care Could Save Your Day

Plum Health

Life happens fast, and sometimes, so do medical issues. Maybe your child develops a sudden fever at 7 PM, or you twist your ankle during a weekend hike. These are the moments when you don’t have time to wait for an appointment with your primary care doctor, and the emergency room (ER) seems like overkill. That’s where urgent care comes in—a middle ground that’s convenient, affordable, and effective.

ER 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Greatest Trick the Devil Ever Pulled was Convincing the World He Didn’t Exist: Senate Judiciary Set to Mark-Up Patent Reform Bills that Could Significantly Affect Hatch-Waxman and the BPCIA

FDA Law Blog

By Kurt R. Karst — “Inter Partes Review” and “Section 101” are not terms you typically run into on this all-things-FDA blog, but we have talked about such patent-related issues before ( here and here ), and they are important legal (patent) principles, particularly in the context of drug and biological products (and the Hatch-Waxman Amendments and the Biologics Price Competition and Innovation Act (“BPCIA”)).

IT 76
article thumbnail

Medical Music Mondays: The World Has Turned And I’m Stuck Here

PEMBlog

Acquired torticollis is a self limited spasm of the neck muscles – often he sternocleidomastoid – that responds well to ibuprofen, heat, and gentle massage and stretching exercises. I thought you’d appreciate the “wry” sense of humor in the album cover… You’d think I’d write a song about asthma and a child that’s a “Weezer?

Asthma 52
article thumbnail

How Doctors Can Save More and Do Less

The Motivated MD

I have spent a lot of time writing other posts lately, and I wanted to take a moment to add another chapter to my regularly scheduled content. For the better half of 2024, I have been periodically writing posts that are individual articles that double as potential chapters to a future book. I have coined this content series Doctor Money: A Personal Finance Guide for Physicians , as this is my current working title.

Finance 52
article thumbnail

The Physicians Foundation Finds that Physician Wellbeing Remains Critically Low; New Survey Unveils Impact of Healthcare Consolidation

The Physicians Foundation

Urgent Need for Solutions to Improve State of Current and Future Physician Wellbeing BOSTON, September 17, 2024 – The Physicians Foundation issued data today showing that the state of wellbeing remains critically low for physicians, with healthcare consolidation exacerbating the issue. Its latest survey, 2024 Survey of America’s Current and Future Physicians , unveils the urgent need to improve physician wellbeing and center physicians’ perspectives in today’s rapidly evolving healthcare landsca

article thumbnail

The National Products Association Challenges FDA’s Interpretation of the Dietary Supplement Exclusionary Clause

FDA Law Blog

By Riëtte van Laack — The dietary supplement exclusionary clause is, as its name suggests, a clause in the Federal Food, Drug, and Cosmetic Act (FDC Act) definition of dietary supplement. That clause excludes those ingredients that were first marketed as drug ingredients. Specifically, FDC Act 201(ff)(3)(B) provides that a dietary supplement does not include: (i) an article that is approved as a new drug under section 355 of [the FDC Act], certified as an antibiotic under section 357 of [the FD

More Trending

article thumbnail

Motivation Monday Recap – September 16th, 2024

The Motivated MD

Happy Motivation Monday! This week we are featuring a handful of articles on a plethora of subjects from various physician finance content creators across the web. I hope you find the below articles informative and entertaining. Have a great week. The Motivated M.D. The first article on our list is our most recent publication. As I celebrate a time in my life where I have freed up discretionary income, I am starting to consider real estate investing.

Finance 52
article thumbnail

OPDP Says TV Ad is Out of Bounds with Fourth Untitled Letter of 2024

FDA Law Blog

By Sarah Wicks & Dara Katcher Levy — FDA’s Office of Prescription Drug Promotion (OPDP) has issued its fourth Untitled Letter of 2024 – this one to AbbVie, Inc. (AbbVie), for a direct-to-consumer (DTC) TV advertisement for its drug UBRELVY (ubrogepant) that features tennis star, social media influencer and entrepreneur Serena Williams. This letter, dated August 29, 2024, (at the height of the US Open, no less) comes not even a month after OPDP’s last letter from August 1, and a little over

Clinic 59
article thumbnail

FDA Publishes Its Draft Strategy Document on Innovative Manufacturing Technologies

FDA Law Blog

By Mark I. Schwartz — FDA recently published a Federal Register (FR) Notice [ Docket No. FDA-2024-N-3945 ] announcing the publication of a draft strategy document, for public comment, outlining specific actions FDA plans to take to facilitate the use of innovative manufacturing technologies. This FR Notice and draft strategy document are part of FDA’s commitment under the Prescription Drug User Fee Act (PDUFA) Reauthorization Performance Goals and Procedures for Fiscal Years 2023-2027 (PDUFA VII